1. Home
  2. RDY vs GGG Comparison

RDY vs GGG Comparison

Compare RDY & GGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • GGG
  • Stock Information
  • Founded
  • RDY 1984
  • GGG 1926
  • Country
  • RDY India
  • GGG United States
  • Employees
  • RDY N/A
  • GGG N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • GGG Fluid Controls
  • Sector
  • RDY Health Care
  • GGG Industrials
  • Exchange
  • RDY Nasdaq
  • GGG Nasdaq
  • Market Cap
  • RDY 11.6B
  • GGG 13.3B
  • IPO Year
  • RDY N/A
  • GGG N/A
  • Fundamental
  • Price
  • RDY $14.86
  • GGG $81.79
  • Analyst Decision
  • RDY Strong Buy
  • GGG Buy
  • Analyst Count
  • RDY 2
  • GGG 2
  • Target Price
  • RDY $16.95
  • GGG $94.00
  • AVG Volume (30 Days)
  • RDY 1.1M
  • GGG 674.7K
  • Earning Date
  • RDY 10-24-2025
  • GGG 10-22-2025
  • Dividend Yield
  • RDY 0.48%
  • GGG 1.35%
  • EPS Growth
  • RDY 2.20
  • GGG N/A
  • EPS
  • RDY 0.79
  • GGG 2.82
  • Revenue
  • RDY $3,897,394,052.00
  • GGG $2,167,974,000.00
  • Revenue This Year
  • RDY $7.33
  • GGG $7.32
  • Revenue Next Year
  • RDY $2.00
  • GGG $4.19
  • P/E Ratio
  • RDY $18.42
  • GGG $28.95
  • Revenue Growth
  • RDY 15.86
  • GGG 0.75
  • 52 Week Low
  • RDY $12.26
  • GGG $72.06
  • 52 Week High
  • RDY $16.17
  • GGG $92.86
  • Technical
  • Relative Strength Index (RSI)
  • RDY 63.75
  • GGG 43.03
  • Support Level
  • RDY $14.00
  • GGG $81.13
  • Resistance Level
  • RDY $14.48
  • GGG $84.40
  • Average True Range (ATR)
  • RDY 0.20
  • GGG 1.56
  • MACD
  • RDY 0.08
  • GGG 0.04
  • Stochastic Oscillator
  • RDY 91.02
  • GGG 35.50

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About GGG Graco Inc.

Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.1 billion in sales in 2024.

Share on Social Networks: